Remestemcel-L

mesenchymal stromal cells · Icahn School of Medicine at Mount Sinai

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Remestemcel-L, covering 2022-03-16 to 2022-04-25. Get the full timeline:

Most recent: Clinical Trial Update: MSCs in COVID-19 ARDS [Phase 3]